Blundell Biotech. Blundell Biotech is a U.S.-based biotechnology company with operations and earnings in a number of foreign countries. The company's profits by subsidiary, in local currency (in millions) along with the average exchange rate for each year, by currency pairs, are shown in the table for 2013 and 2014. Use these data to answer the following questions. a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014? b. If the same exchange rates were used for both years-which is often called a "constant currency basis"- what was the change in corporate earnings on a constant currency basis? c. Using the results of the constant currency analysis in part (b), is it possible to separate Blundell's growth in earnings between local currency earings and foreign exchange rate impacts on a consolidated basis? a. What was Blundell Biotech's consolidated profits in U.S. dollars in 2013 and 2014? Consolidated profits or earnings is found by consolidating the converted profits in each foreign currency to U.S. dollars for that period. (This is simplified. Actual accounting practices would require the additional netting of any intra-company transactions resulting to eliminate any double-counting of profits.) Calculate the consolidated profits in U.S. dollars in 2013 and 2014 below: (Round to two decimal places) Data Table Net Income (USD) Japanese Subsidiary (2013) (Click on the icon to import the table into a spreadsheet.) (2014) Change (%) (a) Net Income 2013 2014 Japanese Subsidiary JPY 1,501 1,455 British Subsidiary GBP 105.09 108.84 European Subsidiary EUR 202.66 208.99 Chinese Subsidiary CNY 168.56 193.46 Russian Subsidiary RUB 124.52 107.47 United States Subsidiary USD 366.87 389.33 USD (b) Exchange Rate 2013 2014 JPY = 1 USD 97.54 105.78 USD = 1 GBP 1.621 1.6184 USD = 1 EUR 1.325 1.4069 CNY = 1 USD 6.1643 6.2176 RUB = 1 USD 31.91 38.55 1 Enter any number in the edit fields and then click Ch 1